The trial was designed 5+ years ago, non-fatal primary endpoint of non-fatal decompensated heart failure events is obsolete and meaningless vs mortality!
Lol, don't let the sharts fool you, they will be all over HC boards.
No other medicine has come even close to reducing Chronic Heart Failure patients mortality by 60%
The gall of downrampers is laughable in this instance.
DYOR
HODL
GLTAB
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-55
-
- There are more pages in this discussion • 968 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |